Combinations of serotonin reuptake inhibitors and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4178 (2006.01) A61K 31/138 (2006.01) A61P 25/18 (2006.01) A61P 25/22 (2006.01)

Patent

CA 2553629

The invention relates to combinations of serotonin reuptake inhibitors and imidazoline l2 agonists as separate chemical units or whose properties are combined in a molecule, and to the use thereof in the production of medicaments for the treatment of depression, obsessive compulsive disorders (OCD), obsessive compulsion spectrum disorders (OCSD) and other anxiety disorders.

La présente invention concerne des associations d'inhibiteurs de reprise de sérotonine et d'agonistes d'imidazoline-l¿2 ?comme unités chimiques séparées ou les deux propriétés réunies dans une molécule. L'invention concerne également leur utilisation pour la production de médicaments destinés au traitement de la dépression, troubles obsessionnels (troubles obsessionnels compulsifs, OCD), troubles de spectre obsessionnel compulsif (OCSD) et autres troubles anxieux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combinations of serotonin reuptake inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combinations of serotonin reuptake inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of serotonin reuptake inhibitors and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1989837

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.